The pet diabetes care devices market comprises blood glucose meters, insulin delivery devices, and other devices that help in managing diabetes in pets. Blood glucose meters help in monitoring the blood sugar levels in pets, while insulin delivery devices such as insulin syringes and pens help in delivering the required dose of insulin. The growing prevalence of diabetes in pets, especially cats and dogs, coupled with increasing awareness about pet health among owners, is fueling the demand for pet diabetes care devices. As per recent studies, nearly 20% of cats and dogs above the age of 15 years suffer from diabetes. With growing humanization of pets and rising pet healthcare expenditure, pet owners are increasingly willing to spend on diabetes management of their pets, which is propelling the pet diabetes care devices market.
The global pet diabetes care devices market is estimated to be valued at USD 2.60 Billion in 2025 and is expected to reach USD 4.26 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 7.3% from 2025 to 2032.
Key Takeaways
Key players operating in the Pet Diabetes Care Devices market are Abbot Laboratories, Inc, Virbac, Medtronic plc, Johnson & Johnson Services, Inc, Roche Diagnostics, Bio-Rad Laboratories, Inc, Novo Nordisk A/S, Zoetis Inc, Terumo Corporation, Boehringer Ingelheim International GmbH, IDEXX Laboratories, Johnson & Johnson Services, Inc, Terumo Corporation, Eli Lilly and Company, Vetoquinol S.A., and i-SENS, Inc.
The Pet Diabetes Care Devices Market Demand is being driven by growing pet obesity rates, with nearly 60% of cats and 50% of dogs being overweight or obese.
Technological advancements in pet diabetes management devices are aiding their widespread adoption. Key players are focusing on developing smart, wearable insulin pumps and blood glucose meters with real-time data monitoring capabilities for pets. This is positively impacting market growth.
Market Trends
Growing availability of generic pet insulin: Major players are focusing on introducing affordable generic versions of pet insulin analogs to increase accessibility and affordability of diabetes management. This is expected to boost market demand over the forecast period.
Rising pet insurance coverage for diabetes management: With increasing pet healthcare costs, more pet owners are opting for pet insurance policies that offer coverage and reimbursement for diabetes treatment. This is anticipated to drive the adoption of diabetes management devices.
Market Opportunities
Untapped markets in developing regions: Emerging markets such as Asia Pacific and Latin America offer lucrative growth opportunities for players. Increasing pet ownership and rising pet health expenditure in these regions will support market expansion.
Technological innovations: Focus on developing innovative, user-friendly devices for diabetes monitoring and insulin delivery in pets, including closed-loop insulin pumps and internet-connected smart devices offers lucrative opportunities.
Impact of COVID-19 on Pet Diabetes Care Devices Market
The outbreak of COVID-19 pandemic has adversely impacted the growth of global pet diabetes care devices market. During the initial phases of nationwide lockdowns imposed by various governments, there was a substantial decline in the sales of pet diabetes care devices. This can be attributed to the closure of non-essential retail stores including veterinary clinics and pet stores. Also, movement restrictions made it difficult for pet owners to physically procure essential supplies and devices for managing their pet’s diabetes. As the pandemic intensified during 2020, the priorities of pet owners shifted to safety and well-being of their families over their pets health needs.
However, as lockdowns eased from mid-2020, the sales of pet diabetes care devices started recovering gradually. Many pet owners continued managing their pet’s diabetes at home with tele consultations from veterinarians. Online channels emerged as the preferred mode of procurement for diabetes care supplies including insulin, syringes, glucose monitors etc. Manufacturers also shifted their marketing and sales strategies to digital platforms to aid continuity of care. It is expected that pent-up demand and restoration of routine veterinary visits would further aid the market to regain lost growth in coming years.
In terms of geography, North America dominates the global pet diabetes care devices market currently in terms of value. This can be attributed to high pet ownership, increasing incidence of diabetes in pets, growing pet humanization and well-established veterinary infrastructure in the region. Additionally, availability of sophisticated devices, reimbursement policies and awareness drives adoption in the US and Canada. However, Asia Pacific region is expected to emerge as the fastest growing market during the forecast period. Rising pet ownership in countries like India and China coupled with growing per capita pet care expenditure are favoring market growth in the region.
Get More Insights – Pet Diabetes Care Devices Market
Get This Report in Japanese Language – ペット糖尿病ケア機器市場
Get This Report in Korean Language –애완동물 당뇨병 관리 장치 시장
About Author:
Vaagisha brings over three years of expertise as a content editor in the market research domain. Originally a creative writer, she discovered her passion for editing, combining her flair for writing with a meticulous eye for detail. Her ability to craft and refine compelling content makes her an invaluable asset in delivering polished and engaging write-ups.
(LinkedIn: https://www.linkedin.com/in/vaagisha-singh-8080b91)